The kidney and hypertension in diabetes mellitus /
Saved in:
| Edition: | 4th ed. |
|---|---|
| Imprint: | Boston : Kluwer Academic Publishers, c1998. |
| Description: | xxvi, 609 p. : ill. ; 24 cm. |
| Language: | English |
| Subject: | |
| Format: | Print Book |
| URL for this record: | http://pi.lib.uchicago.edu/1001/cat/bib/3661966 |
Table of Contents:
- Some keys to the literature
- Contributing authors
- Preface, first edition
- Preface, second edition
- Preface, third edition
- Preface, fourth edition
- Preface, fifth edition
- 1.. Pressure induced and metabolic alterations in the glomerulus: Role in cytokine activity and progressive sclerosis
- 2.. Definition of diabetic renal disease in insulin-dependent diabetes mellitus based on renal function tests
- 3.. Retinopathy in relation to albuminuria and blood pressure in IDDM
- 4.. Microalbuminuria and cardiovascular disease
- 5.. The heart in diabetes: results of trials
- 6.. Albuminuria in non-insulin-dependent diabetes - renal or "extra" renal disease?
- 7.. The clinical course of renal disease in Caucasian NIDDM-patients
- 8.. Serum creatinine and other measures of GFR in diabetes
- 9.. Familial factors in diabetic nephropathy
- 10.. Genetics and diabetic nephropathy
- 11.. Birth, Barker and Brenner: The concept of low birth weight and renal disease
- 12.. Effect of insulin on the kidney and the cardiovascular system
- 13.. Value of screening for microalbuminuria in people with diabetes as well as in the general population
- 14.. Incidence of nephropathy in IDDM as related to mortality. Cost and benefits of early intervention
- 15.. Dysfunction of the vascular endothelium and the development of renal and vascular complications in diabetes
- 16.. Urinary tract infections in patients with diabetes mellitus
- 17.. Light microscopy of diabetic glomerulopathy: the classic lesions
- 18.. Renal structural changes in patients with type 1 diabetes and microalbuminuria
- 19.. Renal structure in type 2 diabetic patients with microalbuminuria
- 20.. Nephropathy in NIDDM patients, predictors of outcome
- 21.. Advanced glycation end-products and diabetic renal disease
- 22.. Protein kinase C in diabetic renal involvement, the perspective of inhibition
- 23.. Biochemical aspects of diabetic nephropathy
- 24.. Pathogenesis of diabetic glomerulopathy: the role of glomerular hemodynamic factors
- 25.. An update on the role of growth factors in the development of diabetic kidney disease
- 26.. Transforming growth factor-[beta] and other cytokines in experimental and human diabetic nephropathy
- 27.. Blood pressure elevation in diabetes: the results from 24-h ambulatory blood pressure recordings
- 28.. Microalbuminuria in young patients with type 1 diabetes
- 29.. Early renal hyperfunction and hypertrophy in IDDM patients including comments on early intervention
- 30.. Diabetes, hypertension, and kidney disease in the Pima Indians
- 31.. Autoregulation of glomerular filtration rate in patients with diabetes
- 32.. ACE-inhibition, angiotensin II receptor blockade, and diabetic nephropathy
- 33.. The concept of incipient diabetic nephropathy and effect of early antihypertensive intervention
- 34.. Reversibility of diabetic nephropathy lesions: A new concept
- 35.. Antihypertensive treatment in NIDDM, with special reference to abnormal albuminuria
- Addendum regarding renovascular hypertension and renal artery stenosis (especially NIDDM)
- 36.. The course of incipient and overt diabetic nephropathy: the perspective of more optimal treatment, including UKPDS-perspective
- 37.. Non-glycaemic intervention in diabetic nephropathy: the role of dietary protein intake
- 38.. Diabetic nephropathy and pregnancy
- 39.. Evolution worldwide of renal replacement therapy in diabetes
- 40.. Haemodialysis and CAPD in type 1 and type 2 diabetic patients with endstage renal failure
- 41.. Renal transplantation for diabetic nephropathy
- 42.. Combination therapy for hypertension and renal disease in diabetes
- 43.. Microalbuminuria in essential hypertension. Significance for the cardiovascular and renal systems
- 44.. A comparison of progression in diabetic and non-diabetic renal disease: similarity of progression promoters
- 45.. Update of the latest intervention trials in hypertension and type 2 diabetes
- 46.. Scientific basis for the new guidelines for the treatment of hypertension in type 2 diabetes
- 47.. Regulatory considerations in the development of therapies for diabetic nephropathy and related conditions
- 48.. The renin angiotensin system in the pathogenesis of diabetic complications
- 49.. Microalbuminuria, blood pressure and diabetic renal disease: Origin and development of ideas
